https://www.openbell.ai/ 2026-10-13T16:36:44.113Z hourly 1.0 https://www.openbell.ai/support 2026-10-13T16:36:44.113Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-13T16:36:44.113Z monthly 0.5 https://www.openbell.ai/terms 2026-10-13T16:36:44.113Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-13T16:36:44.113Z hourly 0.8 https://www.openbell.ai/news/AMAT:1791909374971 2026-10-13T16:36:14.971Z daily 0.9 https://cdn.brandfetch.io/AMAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of semiconductor and chip companies are trading lower as memory stocks slide amid concerns about intensifying Chinese competition, following reports that ChangXin Memory Technologies has made progress on a more efficient, higher-density DRAM design. Chip stocks are also under pressure after South Korea’s Kospi fell 5.5%, with SK Hynix plunging more than 10%  in Seoul trading. openbell Financial News https://www.openbell.ai/news/FUN:1791909374053 2026-10-13T16:36:14.053Z daily 0.9 https://cdn.brandfetch.io/FUN/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Six Flags Closes Ten Rides After Fatal Roller Coaster Accident' - Bloomberg Six Flags has closed ten rides following a fatal accident involving one of its roller coasters. The company is reviewing safety protocols and has stated that the closures are a precautionary measure. The incident has raised concerns about safety in the amusement park industry, potentially impacting visitor attendance and stock performance for Six Flags (ticker: FUN). https://www.openbell.ai/news/MRVL:1791909309119 2026-10-13T16:35:09.119Z daily 0.9 https://cdn.brandfetch.io/MRVL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Marvell Technology; Hearing Investor Business Daily SwingTrader Buys Stock openbell Financial News https://www.openbell.ai/news/SAP:1791909178714 2026-10-13T16:32:58.714Z daily 0.9 https://cdn.brandfetch.io/SAP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on SAP, Raises Price Target to $243 Barclays analyst Raimo Lenschow has maintained an Overweight rating on SAP (NYSE: SAP) and raised the price target from $242 to $243. This adjustment reflects Barclays' positive outlook on the company's performance. https://www.openbell.ai/news/GH:1791909040090 2026-10-13T16:30:40.090Z daily 0.9 https://cdn.brandfetch.io/GH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Guardant Health, Raises Price Target to $200 Morgan Stanley analyst Shannon O'Callaghan has maintained an Overweight rating on Guardant Health (NASDAQ: GH) and increased the price target from $185 to $200. This adjustment reflects the firm's positive outlook on the company's performance. https://www.openbell.ai/news/GRAL:1791908986735 2026-10-13T16:29:46.735Z daily 0.9 https://cdn.brandfetch.io/GRAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Equal-Weight on GRAIL, Raises Price Target to $120 Morgan Stanley analyst Tejas Savant has maintained an Equal-Weight rating on GRAIL (NASDAQ: GRAL) and raised the price target from $60 to $120. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/PEGA:1791908921969 2026-10-13T16:28:41.969Z daily 0.9 https://cdn.brandfetch.io/PEGA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Pegasystems, Raises Price Target to $43 Barclays analyst Raimo Lenschow has maintained an Overweight rating on Pegasystems (NASDAQ: PEGA) and raised the price target from $39 to $43. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/DHR:1791908820822 2026-10-13T16:27:00.822Z daily 0.9 https://cdn.brandfetch.io/DHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Danaher, Raises Price Target to $240 Morgan Stanley analyst Kallum Titchmarsh has maintained an Overweight rating on Danaher (NYSE: DHR) and raised the price target from $220 to $240. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/UNH:1791908804380 2026-10-13T16:26:44.380Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Konskie--Poland---November-13--2024-Unit.jpg?width=250&height=187 UnitedHealth Stock Wobbles Despite 61% Profit Jump, Boosted Outlook UnitedHealth Group Inc. reported a 61% increase in adjusted earnings per share (EPS) to $4.69 for the third quarter, exceeding analyst expectations, with revenue of $112.69 billion also surpassing estimates. The company raised its 2026 adjusted EPS outlook to at least $20.50, up from a previous range of $19.50 to $20, while management indicated that 2027 projections may be conservative. Despite these positive results, UnitedHealth's stock fluctuated, rising 2% before reversing course, and was trading at $380.71 at the time of publication. https://www.openbell.ai/news/V:1791908797614 2026-10-13T16:26:37.614Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Benzinga-Quick-Spark.jpg?width=250&height=187 QUICK SPARK: Visa, Mastercard May Have Less to Fear from Stablecoins Than You Think Visa Inc. (NYSE: V) and Mastercard Inc. (NYSE: MA) may be better positioned to adapt to the rise of stablecoins than investors believe, according to Reeve Collins, co-founder of Tether. He highlights that the established networks' advantages, such as merchant acceptance and fraud protection, remain significant. However, there is a risk that customers may find ways to transact directly, potentially bypassing traditional networks. The future will depend on whether these companies can incorporate blockchain technology to enhance payment efficiency while retaining customer loyalty. https://www.openbell.ai/news/CRL:1791908679134 2026-10-13T16:24:39.134Z daily 0.9 https://cdn.brandfetch.io/CRL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Charles River, Raises Price Target to $340 Morgan Stanley analyst Ricky Goldwasser has maintained an Overweight rating on Charles River (NYSE: CRL) and raised the price target from $300 to $340. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/TTD:1791908665387 2026-10-13T16:24:25.387Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Konskie--Poland---January-22--2024-The-T.jpg?width=250&height=187 The Trade Desk Stock Moves Higher: What's Going On? The Trade Desk Inc. (NASDAQ: TTD) has launched Skydance Corp.'s pause-screen ads for Italian advertisers on HBO Max and discovery+, allowing brands to purchase these ads through its platform. Despite this new offering, TTD shares have fallen 75% over the past year, currently trading at $12.35, which is 77.6% below its 52-week high of $55.11. The stock is also trading below key moving averages, indicating a longer-term downtrend. https://www.openbell.ai/news/SNDX:1791908646850 2026-10-13T16:24:06.850Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Doctor-Hand-Point-Patient-Lung-X-ray-Fil.jpg?width=250&height=187 Syndax Pharmaceuticals Suffers Pipeline Blow Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) has decided to halt the clinical development of axatilimab for idiopathic pulmonary fibrosis (IPF) after the drug failed to meet its primary endpoint in the Phase 2 MAXPIRe trial, which involved 145 patients. Despite the setback, the company confirmed that ongoing trials for axatilimab in other indications, such as chronic graft-versus-host disease (cGVHD), will continue. Following the announcement, Syndax's stock price fell by 16.68% to $13.79. https://www.openbell.ai/news/OHI:1791908600299 2026-10-13T16:23:20.299Z daily 0.9 https://cdn.brandfetch.io/OHI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Underweight on Omega Healthcare Invts, Lowers Price Target to $48 Barclays analyst Richard Hightower has maintained an Underweight rating on Omega Healthcare Investments (NYSE: OHI) and has reduced the price target from $50 to $48. https://www.openbell.ai/news/MSFT:1791908463052 2026-10-13T16:21:03.052Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Microsoft, Raises Price Target to $600 Barclays analyst Raimo Lenschow has maintained an Overweight rating on Microsoft (NASDAQ: MSFT) and raised the price target from $512 to $600. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/TCRT:1791908363350 2026-10-13T16:19:23.350Z daily 0.9 https://cdn.brandfetch.io/TCRT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Alaunos Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 269.52% openbell Financial News https://www.openbell.ai/news/GOOGL:1791908173987 2026-10-13T16:16:13.987Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Stuttgart--Germany---July-20--2023-Googl.jpg?width=250&height=187 Alphabet Could Unlock $100 Billion From AI Chips by 2028, Analyst Says Alphabet Inc. (NASDAQ: GOOG, GOOGL) is projected to unlock $80 billion to $100 billion in revenue from external sales of its Tensor Processing Units (TPUs) by 2028, according to BNP Paribas analyst Nick Jones. He raised his price target for the stock to $450, indicating a 28% upside from its recent price of $351.70. Alphabet is expected to report third-quarter results on October 28, with heightened investor expectations for Google Cloud growth and diluted EPS estimates above $3.20. However, increased TPU sales may pressure Google Cloud's profitability in the near term. https://www.openbell.ai/news/GOOG:1791908156330 2026-10-13T16:15:56.330Z daily 0.9 https://cdn.brandfetch.io/GOOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Google Rolling Out Gemini 4 Argon To Google AI Subscribers In Google Antigravity, Gemini App & AI Mode In Search Google has announced the rollout of its Gemini 4 Argon to subscribers of Google AI, which will be integrated into Google Antigravity, the Gemini app, and the AI mode in Google Search. This update aims to enhance the capabilities of Google's AI offerings. The company continues to innovate in the AI space, reflecting its commitment to advancing technology and improving user experience. https://www.openbell.ai/news/META:1791908124562 2026-10-13T16:15:24.562Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud Meta Platforms Launching New AI-Powered Tools To Shape Feeds, Reels; Updates Three-Dot Menu Meta Platforms has announced the launch of new AI-powered tools designed to enhance user experience by shaping feeds and Reels. Additionally, the company has updated its three-dot menu to improve navigation. These updates are part of Meta's ongoing efforts to leverage artificial intelligence in its services, although specific financial impacts or projections were not disclosed. https://www.openbell.ai/news/IOVA:1791908121929 2026-10-13T16:15:21.929Z daily 0.9 https://cdn.brandfetch.io/IOVA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Iovance Biotherapeutics, Raises Price Target to $18 Barclays analyst Etzer Darout has maintained an Overweight rating on Iovance Biotherapeutics (NASDAQ: IOVA) and raised the price target from $15 to $18. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/C:1791908114686 2026-10-13T16:15:14.686Z daily 0.9 https://cdn.brandfetch.io/C/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup CEO Jane Fraser Says Transformation Costs Are Going Down; Higher Rates May Impact Tenure Of Corporate Debt; Higher Rates Are Not Slowing Down AI Investment; Sees Syndicated Debt Moderated In Favor Of Revolver Lines Due To Flexibility; Investment Banking Pipeline For Fourth Quarter Is Still Strong; Expects Equity Capital Markets To Be More Focused In Follow On Transactions; Expects High Debt Refinancing Activity By Investment Grade Companies During a recent conference call, Citigroup CEO Jane Fraser reported that transformation costs are decreasing and indicated that higher interest rates may affect the tenure of corporate debt. Despite these challenges, she noted that investments in AI are not being hindered by rising rates. Fraser also mentioned a shift towards revolver lines over syndicated debt for increased flexibility and expressed confidence in a strong investment banking pipeline for the fourth quarter, with expectations of heightened debt refinancing activity among investment-grade companies. https://www.openbell.ai/news/ASTS:1791907954107 2026-10-13T16:12:34.107Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/AST-SpaceMobile-Inc.jpg?width=250&height=187 Analyst Sees SpaceX Squeezing AST SpaceMobile on Launch Access and Pricing AST SpaceMobile, Inc. (NASDAQ: ASTS) shares fell 8.88% to $46.89 after Piper Sandler analyst Alexander Potter downgraded the stock from Overweight to Neutral and reduced the price target from $98 to $54. The analyst expressed concerns over delays in satellite launches and competition from SpaceX, which is expanding its direct-to-cell market capabilities. Revised estimates now predict AST SpaceMobile will generate $155 million and $398 million in revenue for 2026 and 2027, respectively, falling short of consensus estimates. https://www.openbell.ai/news/FUN:1791907821005 2026-10-13T16:10:21.005Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/New-Jersey-Usa---June-20-2016-Bizarro-Is.jpg?width=250&height=187 Six Flags Stock Hits 7-Year Low After Roller Coaster Death: What It Means for Jana Partners, Travis Kelce Six Flags Entertainment Corp (NYSE: FUN) shares have fallen to a seven-year low of $9.96, down 16.5% on Tuesday, following the death of a 42-year-old man on the Goliath roller coaster at Six Flags Over Georgia. This incident complicates the activist investor Jana Partners' push for a sale of the company, in which they hold a 9% stake valued at approximately $117.6 million. The stock has declined 35% year-to-date, and the company faces potential legal challenges related to the accident. https://www.openbell.ai/news/XGN:1791907756115 2026-10-13T16:09:16.115Z daily 0.9 https://cdn.brandfetch.io/XGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Maintains Buy on Exagen, Raises Price Target to $11 TD Cowen analyst Dan Bergstrom has maintained a 'Buy' rating on Exagen (NASDAQ: XGN) and increased the price target from $10 to $11. https://www.openbell.ai/news/NTRA:1791907686862 2026-10-13T16:08:06.862Z daily 0.9 https://cdn.brandfetch.io/NTRA/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Maintains Buy on Natera, Raises Price Target to $480 TD Cowen analyst Dan Brennan has maintained a Buy rating on Natera (NASDAQ: NTRA) and increased the price target from $340 to $480. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/BNTX:1791907620021 2026-10-13T16:07:00.021Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Biontech.jpg?width=250&height=187 Why Is BioNTech Stock Falling Tuesday? BioNTech SE (NASDAQ: BNTX) reported initial findings from the AHEAD-MERIT Phase 2/3 clinical trial for its investigational mRNA cancer immunotherapy BNT113, which did not show a statistically significant improvement in progression-free survival compared to pembrolizumab alone. Following this announcement, BioNTech's stock fell by 5.22%, trading at $90.84. The trial will continue to evaluate overall survival as a primary endpoint, as there are currently no approved therapies targeting HPV-positive tumors, which account for a significant portion of head and neck cancers. https://www.openbell.ai/news/FIVN:1791907602951 2026-10-13T16:06:42.951Z daily 0.9 https://cdn.brandfetch.io/FIVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Five9, Raises Price Target to $40 Barclays analyst Raimo Lenschow has maintained an Overweight rating on Five9 (NASDAQ: FIVN) and increased the price target from $34 to $40. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/BNTX:1791907581139 2026-10-13T16:06:21.139Z daily 0.9 https://cdn.brandfetch.io/BNTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is BioNTech Stock Falling Tuesday? BioNTech SE (NASDAQ: BNTX) reported initial findings from its AHEAD-MERIT Phase 2/3 clinical trial for BNT113, an mRNA cancer immunotherapy, which resulted in a stock decline of over 5%. The trial, assessing BNT113 in combination with Merck's Keytruda for advanced head and neck cancer, did not achieve a statistically significant improvement in progression-free survival compared to Keytruda alone. The focus will now shift to the overall survival endpoint, which remains to be evaluated as the trial proceeds. https://www.openbell.ai/news/DT:1791907538060 2026-10-13T16:05:38.060Z daily 0.9 https://cdn.brandfetch.io/DT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Dynatrace, Raises Price Target to $71 Barclays analyst Raimo Lenschow has maintained an Overweight rating on Dynatrace (NYSE: DT) and increased the price target from $60 to $71. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/MU:1791907535130 2026-10-13T16:05:35.130Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of memory- and storage-related chip companies are trading lower amid concerns over Chinese competition, following reports this week that ChangXin Memory Technologies advanced development of a new DRAM cell structure to increase storage density and efficiency. The sector is also under pressure after South Korea’s Kospi fell 5.5% to its lowest level since July 31, with SK Hynix plunging more than 10% in Seoul trading. openbell Financial News https://www.openbell.ai/news/DDOG:1791907488597 2026-10-13T16:04:48.597Z daily 0.9 https://cdn.brandfetch.io/DDOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Datadog, Raises Price Target to $300 Barclays analyst Raimo Lenschow has maintained an Overweight rating on Datadog (NASDAQ: DDOG) and raised the price target from $290 to $300. This adjustment reflects positive sentiment towards the company's performance and growth potential. https://www.openbell.ai/news/LMT:1791907407827 2026-10-13T16:03:27.827Z daily 0.9 https://cdn.brandfetch.io/LMT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lockheed Martin, Avio Announce Strategic Cooperation Agreement For Solid Rocket Motor Production Lockheed Martin and Avio have entered into a strategic cooperation agreement focused on the production of solid rocket motors. This partnership aims to enhance their capabilities in the aerospace sector, leveraging both companies' expertise. The collaboration is expected to strengthen Lockheed Martin's position in the market and support future defense and space initiatives. https://www.openbell.ai/news/GRAL:1791907375720 2026-10-13T16:02:55.720Z daily 0.9 https://cdn.brandfetch.io/GRAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Maintains Buy on GRAIL, Raises Price Target to $180 TD Cowen analyst Dan Brennan has maintained a Buy rating on GRAIL (NASDAQ: GRAL) and increased the price target from $88 to $180. https://www.openbell.ai/news/BFAM:1791907264723 2026-10-13T16:01:04.723Z daily 0.9 https://cdn.brandfetch.io/BFAM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Underweight on Bright Horizons Family, Lowers Price Target to $64 Morgan Stanley analyst Toni Kaplan has maintained an Underweight rating on Bright Horizons Family (NYSE: BFAM) and has lowered the price target from $66 to $64. https://www.openbell.ai/news/NWG:1791907222030 2026-10-13T16:00:22.030Z daily 0.9 https://cdn.brandfetch.io/NWG/w/400/h/400?c=1idopYfmtR7ZKg8QMud NatWest Group shares are trading higher after Barclays upgraded its rating on the stock from Equal-Weight to Overweight. openbell Financial News https://www.openbell.ai/news/DELL:1791907217191 2026-10-13T16:00:17.191Z daily 0.9 https://cdn.brandfetch.io/DELL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Live On CNBC, Michael Dell On AI, Says "I Don't Think There's Enough Supply For This To Be A Bubble"; Good That There's Active Engagement With Communities On Data Centers; Al Impact On The Economy Is Quite Powerful; On Al Safety, Says Think We're All Going To Be Here In 2030, It'll Be Fine; I Think It's Very Important That We Stay Ahead Of The World On Al; Think There's A Role For Government To Play In Al Safety openbell Financial News https://www.openbell.ai/news/BDSX:1791907105822 2026-10-13T15:58:25.822Z daily 0.9 https://cdn.brandfetch.io/BDSX/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Maintains Buy on Biodesix, Raises Price Target to $40 TD Cowen analyst Dan Brennan has maintained a Buy rating on Biodesix (NASDAQ: BDSX) and increased the price target from $30 to $40. https://www.openbell.ai/news/ADPT:1791907021320 2026-10-13T15:57:01.320Z daily 0.9 https://cdn.brandfetch.io/ADPT/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Maintains Buy on Adaptive Biotechnologies, Raises Price Target to $32 TD Cowen analyst Dan Brennan has maintained a Buy rating on Adaptive Biotechnologies (NASDAQ: ADPT) and raised the price target from $28 to $32. https://www.openbell.ai/news/ORCL:1791907014339 2026-10-13T15:56:54.339Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Warsaw--Poland--28-September-2018--Sign-.jpg?width=250&height=187 Oracle Stock Moves Higher: What's Happening? Oracle Corp (NYSE: ORCL) shares increased by 0.79% to $138.47, having traded above $140 earlier in the day. The company proposed an Energy Service Agreement with El Paso Electric, committing to $10 million annually for ten years for electricity supply related to its Project Jupiter data center. Additionally, Oracle, along with Microsoft and Marvell, formed a security group to create a common design for an integrated hardware security module aimed at enhancing cloud data center security. https://www.openbell.ai/news/RL:1791906876850 2026-10-13T15:54:36.850Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Paris---France--05-05-2025--Luxury-Bouti.jpg?width=250&height=187 Ralph Lauren Analyst Expects Beat-And-Raise Q2, Says Concerns Are ‘Overblown’ Ralph Lauren Corp (NYSE: RL) is expected to report better-than-expected Q2 fiscal 2027 earnings, with analyst Kendall Toscano from BofA Securities predicting a beat-and-raise outcome. Toscano maintains a Buy rating with a price target of $450, citing the company's resilience amidst freight concerns and a weakening U.S. consumer backdrop. He anticipates a 90 basis point year-on-year expansion in EBIT margin and a 60 basis point increase in gross margin, driven by growth in average unit retail prices. Despite a slight decline in stock price to $372.86, Toscano believes the company's higher-income customer base remains strong and is likely to gain market share in Europe. https://www.openbell.ai/news/TMO:1791906863448 2026-10-13T15:54:23.448Z daily 0.9 https://cdn.brandfetch.io/TMO/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $760 TD Cowen analyst Dan Brennan has maintained a Buy rating on Thermo Fisher Scientific (NYSE: TMO) and increased the price target from $675 to $760. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/TEAM:1791906744194 2026-10-13T15:52:24.194Z daily 0.9 https://cdn.brandfetch.io/TEAM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Atlassian, Raises Price Target to $222 Barclays analyst Raimo Lenschow has maintained an Overweight rating on Atlassian (NASDAQ: TEAM) and raised the price target from $172 to $222. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/RVTY:1791906525666 2026-10-13T15:48:45.666Z daily 0.9 https://cdn.brandfetch.io/RVTY/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Maintains Buy on Revvity, Raises Price Target to $175 TD Cowen analyst Dan Brennan has maintained a Buy rating on Revvity (NYSE: RVTY) and increased the price target from $130 to $175. https://www.openbell.ai/news/CBRS:1791906489883 2026-10-13T15:48:09.883Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Cerebras-logo-on-window.jpg?width=250&height=187 Cerebras Stock Braces for 19.4 Million-Share Unlock After Record Low Cerebras Systems Inc. (NASDAQ: CBRS) is set to unlock up to 19.4 million shares for sale on Wednesday, following a recent decline in stock price, which fell 10.7% to $146.62, marking a 58% drop from its $350 opening price in May. The company has been releasing insider stock in stages, with the last tranche unlocking on September 30, which caused an 8.9% drop in stock value. Additionally, concerns have arisen regarding Cerebras' relationship with its major customer, OpenAI, after reports indicated that OpenAI would utilize NVIDIA GPUs instead of Cerebras hardware for its upcoming projects, leading to a significant decline in stock value over the past weeks. https://www.openbell.ai/news/NVDA:1791906483533 2026-10-13T15:48:03.533Z daily 0.9 https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud NVIDIA Says Will Announce $2B Of AI Investments In Europe This Week NVIDIA announced plans to invest $2 billion in artificial intelligence initiatives in Europe, with the announcement expected this week. This investment is part of NVIDIA's broader strategy to expand its presence in the AI sector. The company's stock ticker is NVDA. https://www.openbell.ai/news/NVDA:1791906440077 2026-10-13T15:47:20.077Z daily 0.9 https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud NVIDIA Says Will Announce $2b Of AI Investments In Europe This Week NVIDIA announced plans to invest $2 billion in artificial intelligence initiatives in Europe, with the announcement expected to be made this week. This investment is part of NVIDIA's broader strategy to enhance its AI capabilities and strengthen its presence in the European market. The company's stock ticker is NVDA. https://www.openbell.ai/news/MPC:1791906376736 2026-10-13T15:46:16.736Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Benzinga-Quick-Spark.jpg?width=250&height=187 QUICK SPARK: Marathon Petroleum Nears 10-Month Winning Streak Last Seen In 2013 Marathon Petroleum Corp. (NYSE: MPC) is on the verge of achieving a ten-month winning streak, last seen in 2013, with shares trading at $466.02. The stock has increased by 17.9% in October and 186.6% in 2026, with the streak continuing if October closes above $395.42. The company is set to report its third-quarter results on November 3, and it is the largest holding in the VanEck Oil Refiners ETF, which has risen approximately 77% this year. https://www.openbell.ai/news/DHR:1791906308895 2026-10-13T15:45:08.895Z daily 0.9 https://cdn.brandfetch.io/DHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Maintains Buy on Danaher, Raises Price Target to $255 TD Cowen analyst Dan Brennan has maintained a Buy rating on Danaher (NYSE: DHR) and increased the price target from $236 to $255. https://www.openbell.ai/news/ACI:1791905998948 2026-10-13T15:39:58.948Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/13/Albertsons-Companies-Inc.jpg?width=250&height=187 Albertsons Executive Sounds Alarm: 'Dramatic Improvement Is Needed Now' Albertsons Companies, Inc. reported second-quarter fiscal 2026 results with adjusted earnings of 36 cents per share, surpassing the analyst estimate of 33 cents. Despite a slight decline in net sales to $18.895 billion, this figure exceeded the consensus estimate of $18.867 billion. The company has withdrawn its fiscal 2026 outlook amid a comprehensive business review and is considering strategic changes to improve operations and shareholder value. Albertsons shares rose 2.23% to $12.82 following the announcement. https://www.openbell.ai/news/A:1791905962822 2026-10-13T15:39:22.822Z daily 0.9 https://cdn.brandfetch.io/A/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $196 TD Cowen analyst Dan Brennan has maintained a Buy rating on Agilent Technologies (NYSE: A) and increased the price target from $180 to $196. This adjustment reflects positive expectations for the company's performance in the market.